Relative Effects of Omission Training and Extinction Training in Obese Subjects

1977 ◽  
Vol 27 (2) ◽  
pp. 449-456 ◽  
Author(s):  
Jeff S. Topping ◽  
Cynthia M. Surratt ◽  
Billy A. Barrios
Keyword(s):  
Extinction Training ◽  
Omission Training ◽  
Obese Subjects

scholarly journals Comparison of omission training and extinction training in mentally retarded individuals

1976 ◽  
Vol 8 (3) ◽  
pp. 211-214 ◽  
Author(s):  
Jeff S. Topping ◽  
Helen J. Thompson ◽  
Billy A. Barrios
Keyword(s):  
Mentally Retarded ◽  
Extinction Training ◽  
Omission Training

Baseline Response Rate and its Relationship to Effects of Omission and Extinction Training in Pigeons

1977 ◽  
Vol 40 (3) ◽  
pp. 971-979 ◽  
Author(s):  
Jeff S. Topping ◽  
James T. Crowe
Keyword(s):  
Response Rate ◽  
Short Interval ◽  
Training Group ◽  
Extinction Training ◽  
Omission Training ◽  
Baseline Response Rate ◽  
Differential Effects ◽  
Training Groups ◽  
Baseline Response ◽  
The Relationship

Two experiments were conducted to examine the relationship between baseline response rate and the effects of omission training and extinction training in pigeons. Exp. 1 employed four omission-training groups, differentiated by the values of the reinforcement-reinforcement and/or response-reinforcement intervals, and an extinction-training group while Exp. 2 used two omission-training groups and an extinction-training group. Results indicated that baseline response rate was not related to the differential effects of omission training and extinction training and that omission-training groups with relatively short interval values reduced responding significantly faster than did extinction-training groups.

Abstract #724: Bariatric Surgery Restores Both Cardiac and Sudomotor Autonomic C-Fiber Dysfunction Towards Normal in Obese Subjects with Type 2 Diabetes

2016 ◽  
Vol 22 ◽  
pp. 159
Author(s):  
Carolina Casellini ◽  
Joshua Edwards ◽  
Henri Parson ◽  
Kim Hodges ◽  
David Lieb ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Bariatric Surgery ◽  
C Fiber ◽  
Obese Subjects

Multicomponential VR-Enhanced Treatment of Emotional Overeating in Obese Subjects: A Controlled Clinical Trial

2006 ◽  
Author(s):  
Gian Mauro Manzoni ◽  
Gian Luca Cesa ◽  
Daniela Villani ◽  
Gianluca Castelnuovo Enrico Molinari ◽  
Giuseppe Riva
Keyword(s):  
Clinical Trial ◽  
Controlled Clinical Trial ◽  
Obese Subjects

Effects of a Low Carbohydrate Weight Loss Diet on Exercise Capacity and Tolerance in Obese Subjects

Obesity ◽  
2009 ◽  
Author(s):  
Grant D. Brinkworth ◽  
Manny Noakes ◽  
Peter M. Clifton ◽  
Jonathan D. Buckley
Keyword(s):  
Weight Loss ◽  
Exercise Capacity ◽  
Weight Loss Diet ◽  
Low Carbohydrate ◽  
Obese Subjects

Metformin Decreases the High Plasminogen Activator Inhibition Capacity, Plasma Insulin and Triglyceride Levels in Non-Diabetic Obese Subjects

1987 ◽  
Vol 57 (03) ◽  
pp. 326-328 ◽  
Author(s):  
Ph Vague ◽  
I Juhan-Vague ◽  
M C Alessi ◽  
C Badier ◽  
J Valadier
Keyword(s):  
Plasminogen Activator ◽  
Fibrinolytic Activity ◽  
Plasma Insulin ◽  
Normal Glucose Tolerance ◽  
Double Blind Study ◽  
Obese Women ◽  
Double Blind ◽  
Normal Glucose ◽  
Plasma Insulin Levels ◽  
Obese Subjects

SummaryWe have previously observed a positive correlation between Plasminogen Activator Inhibition capacity (PA Inhibition), Body Mass Index (BMI) and plasma insulin levels in a population of non diabetic subjects. The anti diabetic biguanide Metformin which decreases insulin resistance has been reported to increase the blood fibrinolytic activity. Therefore we have studied the effect of Metformin on PA Inhibition levels in obese subjects with normal glucose tolerance. Eighteen obese women (O) (BMI: 31.4 ± 1.13, m ± S.E.M.) were compared to age matched controls (C) (BMI: 20.2 ± 0.8) and randomized to a 15 days treatment by Metformin (M) (1.7 g/day) or placebo (P) in a double blind study while on a weight maintaining diet. O compared to C had higher levels (m ± S.E.M.) of PA Inhibition (9 ± 1.8 IU/ml, versus 2.88 ± 0.29 p <0.01), lower euglobulin fibrinolytic activity (EFA) (4.95 ±1.17 mm versus 9 ± 0.29 p <0.05), higher plasma insulin (24.1 ±2.1. uU/ml), versus 12 ± 1 p <0.01) and triglyceride (1.32 ± 0.16 mmol/1, versus 0.8 ± 0.08 p <0.05). After 15 days of treatment, in group M a significant decrease in PA Inhibition (5.51 ± 1.4, versus 9.48 ±2.1 p <0.05) in plasma insulin (18.5 ±0.1, versus 24.5 ± 3.5, p <0.05) and plasma triglyceride (1.08 ± 0.1, versus 1.47 ± 0.3 p <0.05) and an increase in EFA (6.50 ± 0.28, versus 5.25 ± 0.35 p <0.05) were observed. No significant variation was observed in group P.

Sign in / Sign up

Export Citation Format

Share Document